Subscribe to our Newsletters !!

    Kumar Jeetendra

    How COVID-19 smell, taste misfortune varies from basic virus decoded

    To get a runny or blocked noseand cannot detect sweet or bitter tastes, a new study published on August 19 has discovered. The study is the first to evaluate how people with COVID-19 smell and taste disorders differ from people with other causes of upper respiratory tract infections, according to the researchers, including those in

    Oxford-AstraZeneca antibody might be the main shot accessible for Indians

    Amid the COVID-19 pandemic, India appears for Oxford-AstraZeneca vaccine candidate are the likely first shot available for Indians at the end of 2020. Additionally, there are two indigenously developed vaccine candidates, that are likewise being anticipated to have started with a gap few weeks if removed in trials, said a report from The Times of

    CARE consortium dispatches to quicken drug discovery and improvement for COVID-19

    Using a grant approximately $77.7 million, CARE is funded by cash donations by the European Union (EU) and money and in-kind contributions from Australian European Federation of Pharmaceutical Industries and Associations (EFPIA) businesses and three IMI-Associated Partners. CARE is a five-year project bringing together 37 partners from Belgium, China, Denmark, France, Germany, the Netherlands, Poland,

    Cipla and Stempeutics collaborate for launch of Stempeucel®, first ‘Made in India’ Cell Therapy to treat Critical Limb Ischemia (CLI)

    India, Mumbai, August 20th , 2020: Cipla Limited (BSE: 500087; NSE: CIPLA EQ) referred to as “Cipla” today announced that its partner Stempeutics Research Pvt. Ltd has received regulatory approval by the Drug Controller General of India (DCGI) for the launch of Stempeucel® in India. The product is indicated for the treatment of CLI due

    Examination shows how a protein prevents cells from assaulting their own DNA

    Viruses multiply by injecting their DNA into a host cell. Once it passes the intracellular fluid, then this foreign substance triggers a defense mechanism referred to as the cGAS-STING pathway. This, in turn, binds to another protein named Stimulator of Interferon Genes (STING), which induces an inflammatory immune reaction. From time to time, the material

    Kids are quiet spreaders of COVID-19: Study

    Kids play a larger part in the community spread of COVID-19 than previously thought, according to a study which found that the younger individuals might not be as inclined to become seriously sick as adults, but they can spread infection and bring the virus into their houses. The study, published in the Journal of Pediatrics,

    AnteoTech’s COVID-19 antigen and Flu A&B test distinguishes SARS-Cov-2, flu in under 15 minutes

    AnteoTech Ltd has developed proof-of-concept COVID-19 antigen and Flu A&B point-of-care lateral flow tests which could detect the existence of SARS-Cov-2 and influenza in under 15 minutes. The tests utilize AnteoTech’s patented AnteoBind™ activated europium technologies and provide considerably higher sensitivity than that provided by currently available COVID-19 tests. AnteoTech intends for the tests to

    The Native Antigen Company declares custom agreement administration to create flu An and B antigens

    The Native Antigen Company (now part of LGC’s Clinical Diagnostics Division), among the world’s leading suppliers of reagents which enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the debut of its custom contract agency to rapidly develop antigen panels for influenza A and B viruses. This new service provides

    Self-gathered salivation and profound nasal swabs are similarly powerful for recognizing SARS-CoV-2

    The analysis, published in the Journal of Clinical Microbiology, signifies one of the biggest prospective specimen type comparisons to date, stated Julio Delgado, MD, MS, ARUP principal medical officer. Researchers also found that specimens self-collected in the front part of the nose are somewhat less powerful than deep nasal swabs for virus discovery. This finding

    ICMR creating entrance for data on COVID-19 antibody

    New Delhi, Aug 22 (PTI) The apex health research body, ICMR, is in the process of developing a vaccine portal which will offer information associated with the COVID-19 vaccine growth in India and abroad, with the majority of the upgrades in several regional languages along with English. The goal of producing the portal is to